CEACAM5 and neoplasm: Tumor markers at the time of diagnosis were assessed and elevated carcinoembryonic antigen (CEA), cancer antigen (CA) 19-9, CA125, CA15-3, and alpha fetoprotein (AFP) were recorded in 32 (30.2%), 26 (24.5%), 24 (22.6%), 6 (5.6%) and 3 (2.8%) patients, respectively.